Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Siddharth Bhende

Vascular Surgery Virginia Beach, VA Medical Doctor

NPI 1043535602 CMS profile 184058

397 Little Neck Rd Ste 120, Ste 305, Virginia Beach, VA 23452

Open in the dashboard

General payments

$56,471

579 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Siddharth Bhende of Virginia Beach, VA is reported in the CMS Open Payments database as having received $56,471 across 579 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $7,335 82
2024 General $6,345 95
2023 General $14,123 94
2022 General $17,576 101
2021 General $2,375 38
2020 General $1,884 40
2019 General $6,832 129

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Siddharth Bhende
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Siddharth Bhende were reported at $7,335. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Siddharth Bhende Vascular Surgery median Middle half National median
2019 $6,832 $796 $226–$2,363 $163
2020 $1,884 $348 $118–$1,110 $114
2021 $2,375 $471 $158–$1,421 $132
2022 $17,576 $725 $222–$2,183 $149
2023 $14,123 $836 $257–$2,440 $160
2024 $6,345 $909 $252–$2,619 $164
2025 $7,335 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $33,639 224 payments
  2. Medtronic Vascular, Inc. $5,296 76 payments
  3. Inari Medical, Inc. $4,571 77 payments
  4. W. L. Gore & Associates, Inc. $2,732 42 payments
  5. Penumbra, Inc. $2,644 17 payments
  6. Bard Peripheral Vascular, Inc. $1,409 51 payments
  7. Silk Road Medical, Inc. $1,002 12 payments
  8. Stryker Corporation $802 15 payments
  9. Endologix, Inc. $741 10 payments
  10. Abbott Laboratories $733 8 payments
  11. Other $2,902 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $31,224 536 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,150 6 payments
  3. Travel and Lodging $8,097 37 payments
Products named General payments · program years 2019–2025
  1. HawkOne Directional Atherectomy Devices $17,414 51 payments
  2. ENDURANT IIS $8,789 119 payments
  3. FLOWTRIEVER CATHETER, S $4,802 84 payments
  4. CT THROMBECTOMY SYSTEM KIT $4,615 72 payments
  5. IN.PACT Admiral $3,805 13 payments
  6. Indigo System $2,551 14 payments
  7. HawkOne Directional Atherectomy Devices $2,057 9 payments
  8. Heli-FX EndoAnchor System $1,370 6 payments
  9. Endurant $1,063 18 payments
  10. C3 Delivery System $1,052 18 payments
  11. Other $16,964 303 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

205

Median for Vascular Surgery: 122

Drug cost

$9,403

Median for Vascular Surgery: $14,135

Branded share of claims

86.8%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 11 $7,486
Clopidogrel Clopidogrel Bisulfate Brand 88 $959
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 79 $648
Atorvastatin Calcium Generic 16 $297
Ibuprofen Generic 11 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 129 billing codes

Paid by Medicare

$327,385

Medicare's payments for the services billed

Medicare patients

2,341

Average age 75

Services billed

4,254

1,246 women, 1,095 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 57%
Diabetes 44%
Ischemic heart disease 41%
Chronic kidney disease 39%
Heart failure 34%
Atrial fibrillation 26%
COPD 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

579 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record